Royce & Associates’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.65M | Buy |
307,488
+16,781
| +6% | +$418K | 0.08% | 366 |
|
|
2025
Q1 | $9.01M | Buy |
290,707
+35,155
| +14% | +$1.09M | 0.1% | 310 |
|
|
2024
Q4 | $8.06M | Buy |
255,552
+140,584
| +122% | +$4.43M | 0.07% | 380 |
|
|
2024
Q3 | $6.66M | Buy |
114,968
+100,000
| +668% | +$5.79M | 0.06% | 420 |
|
|
2024
Q2 | $607K | Hold |
14,968
| – | – | 0.01% | 775 |
|
|
2024
Q1 | $629K | Buy |
+14,968
| New | +$629K | 0.01% | 770 |
|
|
2019
Q2 | – | Sell |
-22,859
| Closed | -$419K | – | 1199 |
|
|
2019
Q1 | $419K | Sell |
22,859
-42,125
| -65% | -$772K | ﹤0.01% | 933 |
|
|
2018
Q4 | $1.29M | Sell |
64,984
-21,000
| -24% | -$417K | 0.01% | 822 |
|
|
2018
Q3 | $1.9M | Buy |
+85,984
| New | +$1.9M | 0.01% | 838 |
|
|
2018
Q2 | – | Sell |
-208
| Closed | -$3K | – | 1261 |
|
|
2018
Q1 | $3K | Buy |
+208
| New | +$3K | ﹤0.01% | 1251 |
|